WELLS FARGO & COMPANY/MN - PARATEK PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$48,138
-14.0%
21,782
-1.1%
0.00%
Q1 2023$55,966
+24.4%
22,034
-8.4%
0.00%
Q4 2022$44,983
+73.0%
24,055
+143.5%
0.00%
Q3 2022$26,000
+36.8%
9,879
-0.3%
0.00%
Q2 2022$19,000
-93.3%
9,905
-89.6%
0.00%
Q1 2022$284,000
-72.7%
95,604
-58.8%
0.00%
Q4 2021$1,042,000
-9.9%
232,202
-2.4%
0.00%
Q3 2021$1,157,000
-37.9%
237,988
-12.9%
0.00%
Q2 2021$1,863,000
+14.2%
273,324
+18.2%
0.00%
Q1 2021$1,632,000
+97.1%
231,169
+74.9%
0.00%
Q4 2020$828,000
+38.0%
132,202
+19.2%
0.00%
Q3 2020$600,000
+1.5%
110,938
-2.0%
0.00%
Q2 2020$591,000
+322.1%
113,179
+155.4%
0.00%
Q1 2020$140,000
+115.4%
44,317
+175.8%
0.00%
Q4 2019$65,000
-5.8%
16,071
+0.5%
0.00%
Q3 2019$69,000
+16.9%
15,986
+10.1%
0.00%
Q2 2019$59,000
-86.3%
14,513
-82.0%
0.00%
Q1 2019$432,000
+11.9%
80,675
+7.1%
0.00%
Q4 2018$386,000
-8.5%
75,306
+72.6%
0.00%
Q3 2018$422,000
+7.4%
43,643
+13.1%
0.00%
Q2 2018$393,000
+10.1%
38,587
+40.3%
0.00%
Q1 2018$357,000
+3.2%
27,498
+42.0%
0.00%
Q4 2017$346,000
-18.0%
19,358
+15.1%
0.00%
Q3 2017$422,000
+2.7%
16,825
-1.5%
0.00%
Q2 2017$411,000
+37.0%
17,075
+9.7%
0.00%
Q1 2017$300,000
+37.6%
15,566
+9.9%
0.00%
Q4 2016$218,000
+109.6%
14,166
+77.0%
0.00%
Q3 2016$104,000
+173.7%
8,005
+196.5%
0.00%
Q2 2016$38,000
-11.6%
2,700
-4.7%
0.00%
Q1 2016$43,000
-20.4%
2,8320.0%0.00%
Q4 2015$54,0000.0%2,832
-0.5%
0.00%
Q3 2015$54,000
+200.0%
2,846
+310.7%
0.00%
Q2 2015$18,000
-94.2%
693
-92.9%
0.00%
Q1 2015$308,000
+16.7%
9,820
+43.5%
0.00%
Q4 2014$264,0006,8450.00%
Other shareholders

There were no reported owners of PARATEK PHARMACEUTICALS INC in Q3 2023.

NameSharesValueWeighting ↓
View complete list of PARATEK PHARMACEUTICALS INC shareholders